Unique ID issued by UMIN | UMIN000012422 |
---|---|
Receipt number | R000014542 |
Scientific Title | Examination of the perioperative period hemoglobin and a renal function by patient of hepatocellular carcinoma who undergoes intraoperative blood salvage for a extraction operation. |
Date of disclosure of the study information | 2014/01/06 |
Last modified on | 2014/01/24 09:01:38 |
Examination of the perioperative period hemoglobin and a renal function by patient of hepatocellular carcinoma who undergoes intraoperative blood salvage for a extraction operation.
Examination of the perioperative period hemoglobin and a renal function by patient of hepatocellular carcinoma who undergoes intraoperative blood salvage for a extraction operation.
Examination of the perioperative period hemoglobin and a renal function by patient of hepatocellular carcinoma who undergoes intraoperative blood salvage for a extraction operation.
Examination of the perioperative period hemoglobin and a renal function by patient of hepatocellular carcinoma who undergoes intraoperative blood salvage for a extraction operation.
Japan |
hepatocellular carcinoma
Nephrology | Hepato-biliary-pancreatic surgery |
Malignancy
NO
To examination of the maintenance of perioperative period hemoglobin and volume of blood salvage by renal function by patient of hepatocellular carcinoma who undergoes intraoperative blood salvage for a extraction operation.
Safety,Efficacy
1.Volume of blood salvage by renal function.
2.Maintenance of perioperative period hemoglobin
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Epoetin Beta 24000IU
20 | years-old | <= |
Not applicable |
Male and Female
1. Patient of hepatocellular carcinoma who undergoes intraoperative blood salvage for a extraction operation.
2. Patients acquired informed consent about this study and fill in consent document after they gives sufficient explanation.
1. Patients with known hypersensitivity to Erythropoiesis-stimulating agents (Epoetin alfa,Epoetin beta, Darbepoetin alfa,Epoetin beta pegol)
2. Patients under 20 years old.
3. Patients judged inappropriate by attending physicians.
50
1st name | |
Middle name | |
Last name | Masaki kaibori |
Kansai Medical University
Surgery
2-5-1 sinmachi Hirakata city Osaka
072-804-0101
kaibori@hirakata.kmu.ac.jp
1st name | |
Middle name | |
Last name | Masaki kaibori |
Kansai Medical University
Surgery
2-5-1 sinmachi Hirakata city Osaka
072-804-0101
kaibori@hirakata.kmu.ac.jp
Kansai Medical University
None
Self funding
NO
2014 | Year | 01 | Month | 06 | Day |
Unpublished
Open public recruiting
2013 | Year | 11 | Month | 08 | Day |
2014 | Year | 02 | Month | 01 | Day |
2013 | Year | 11 | Month | 27 | Day |
2014 | Year | 01 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014542
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |